LifeVantage Co. (NASDAQ:LFVN – Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.64 and traded as high as $8.57. LifeVantage shares last traded at $8.35, with a volume of 77,470 shares traded.
LifeVantage Price Performance
The business’s 50-day moving average is $6.97 and its two-hundred day moving average is $6.64. The firm has a market cap of $106.05 million, a P/E ratio of 29.82 and a beta of 0.81.
LifeVantage (NASDAQ:LFVN – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $0.21 earnings per share for the quarter. LifeVantage had a return on equity of 27.02% and a net margin of 1.75%. The company had revenue of $48.25 million during the quarter.
Hedge Funds Weigh In On LifeVantage
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Read More
- Five stocks we like better than LifeVantage
- How to Invest in Biotech Stocks
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- What is MarketRank™? How to Use it
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.